Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|February 17, 2016
Comparison of in vitro antileukemic activity of obatoclax and ABT-737Małgorzata Opydo-Chanek, Lidia MazurNeuroscience Letters|October 19, 2010
Response of astrocytes and microglia/macrophages to brain injury after bone marrow stromal cell transplantation: a quantitative studyMałgorzata Opydo-Chanek, Zbigniew DąbrowskiAnti-Cancer Drugs|March 24, 2011
Glufosfamide as a new oxazaphosphorine anticancer agentLidia Mazur, Małgorzata Opydo-Chanek, Marta StojakIndian Journal of Experimental Biology|November 16, 2013
In vitro cytotoxicity testing of new generation oxazaphosphorines against human histiocytic lymphoma cellsMałgorzata Opydo-Chanek, Lidia Mazur, Marta StojakBiochemical Pharmacology|March 15, 2017
Multifaceted anticancer activity of BH3 mimetics: Current evidence and future prospectsMałgorzata Opydo-Chanek, Oscar Gonzalo, Isabel MarzoToxicology in Vitro : an International Journal Published in Association with BIBRA|April 4, 2017
Combination of ABT-737 and resveratrol enhances DNA damage and apoptosis in human T-cell acute lymphoblastic leukemia MOLT-4 cellsMałgorzata Opydo-Chanek, Agnieszka Rak, Agnieszka Cierniak, et al.Folia Biologica|June 18, 2013
In vitro effects of new generation oxazaphosphorines on human promyelocytic leukemia cellsLidia Mazur, Małgorzata Opydo-Chanek, Marta Stojak, et al.Folia Biologica|March 21, 2012
Comparative effects of new generation oxazaphosphorines on the size and viability of human acute myeloblastic leukemia cellsLidia Mazur, Małgorzata Opydo-Chanek, Katarzyna Wojcieszek, et al.Investigational New Drugs|May 6, 2020
The pan-Bcl-2 inhibitor obatoclax promotes differentiation and apoptosis of acute myeloid leukemia cellsMałgorzata Opydo-Chanek, Iwona Cichoń, Agnieszka Rak, et al.Anticancer Research|December 16, 2014
Cell-cycle disturbance and induction of programmed death by new formamidine analogs of daunorubicinMarta Stojak, Małgorzata Lukawska, Irena Oszczapowicz, et al.Pageof 2